Biocon Ltd. on Monday, July 7, said its subsidiary Biocon Biologics Ltd has secured marketing authorisation from the Medicines and Healthcare products Regulatory Agency...
Novartis wins approval: First malaria treatment drug for newborns and babies is here Times of IndiaFirst malaria treatment for babies approved for use BBCThe first drug...
Aurobindo Pharma Ltd's wholly-owned step-down subsidiary, CuraTeQ Biologics, has received marketing authorisation from the European Commission for its trastuzumab biosimilar, Dazublys.This regulatory milestone follows...